Condition

HCV

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 18 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials18
Recruiting3
Common interventions19
Lead sponsors shown15
Advertisement

Clinical trials

18 shown
Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With BulvertideNCT07429864 · 2025-09-24
RECRUITING
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)NCT07170748 · 2025-07-29
RECRUITING
A Setting Focus Overdose Prevention InterventionNCT05320835 · 2022-04-30
RECRUITING
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex TraffickingNCT07264582 · 2026-10-01
NOT_YET_RECRUITING
National Rapid TLC: Testing and Linkage to CareNCT07730801 · 2026-08-01
NOT_YET_RECRUITING
HIV/HBV/HCV Triple Screening in Primary CareNCT07031219 · 2026-06-01
NOT_YET_RECRUITING
Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, SwitzerlandNCT07516912 · 2026-04-07
NOT_YET_RECRUITING
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York CityNCT06316739 · 2024-05-01
ACTIVE_NOT_RECRUITING
Tools to Identify People At Risk or Already Infected with HIV and HCVNCT06528626 · 2023-07-01
UNKNOWN
Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid SyndromeNCT05597800 · 2023-02-01
NOT_YET_RECRUITING
The South-East Asian Transgender Health CohortNCT05454579 · 2022-12-02
COMPLETED
Appalachian Partnership to Reduce Disparities (Aim 2)NCT04378439 · 2022-04-01
COMPLETED
HCV, HBV, HIV Testing During Consultation With AnesthesiologistNCT04286347 · 2021-08-05
TERMINATED
Integrated HIV Prevention and HCV Care for PWIDNCT03981445 · 2019-11-14
ACTIVE_NOT_RECRUITING
Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky BehaviorNCT03221309 · 2017-05-01
COMPLETED
VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy VolunteerNCT00828789 · 2009-02-01
COMPLETED
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresNCT00678587 · 2008-06-01
TERMINATED
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected IndividualsNCT00489385 · 2007-06-18
COMPLETED

Common interventions

Leading sponsors

Trial status mix

COMPLETED5
NOT_YET_RECRUITING5
RECRUITING3
ACTIVE_NOT_RECRUITING2
TERMINATED2
UNKNOWN1

Phase mix

NA9
PHASE12
PHASE21
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.